Connection

John Colwell to Diabetic Angiopathies

Back to Details
This is a "connection" page, showing publications John Colwell has written about Diabetic Angiopathies.
John Colwell
Connection Strength
3.099
Diabetic Angiopathies
  1. An appraisal of aspirin therapy in diabetes. Curr Diab Rep. 2006 Dec; 6(6):409-10.
    View in: PubMed
    Score: 0.262
  2. Aspirin therapy in diabetes. Diabetes Care. 2004 Jan; 27 Suppl 1:S72-3.
    View in: PubMed
    Score: 0.214
  3. Aspirin for primary prevention of cardiovascular events in diabetes. Diabetes Care. 2003 Dec; 26(12):3349-50.
    View in: PubMed
    Score: 0.213
  4. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care. 2003 Jul; 26(7):2181-8.
    View in: PubMed
    Score: 0.206
  5. Aspirin therapy in diabetes. Diabetes Care. 2003 Jan; 26 Suppl 1:S87-8.
    View in: PubMed
    Score: 0.199
  6. Hemoglobin A1c is not the only issue. Curr Diab Rep. 2002 Aug; 2(4):295-6.
    View in: PubMed
    Score: 0.194
  7. Prevention of diabetes complications. Clin Cornerstone. 1998; 1(3):58-71.
    View in: PubMed
    Score: 0.141
  8. Elevated plasma homocysteine and diabetic vascular disease. Diabetes Care. 1997 Dec; 20(12):1805-6.
    View in: PubMed
    Score: 0.140
  9. Multifactorial aspects of the treatment of the type II diabetic patient. Metabolism. 1997 Dec; 46(12 Suppl 1):1-4.
    View in: PubMed
    Score: 0.140
  10. Pharmacological strategies to prevent macrovascular disease in NIDDM. Diabetes. 1997 Sep; 46 Suppl 2:S131-4.
    View in: PubMed
    Score: 0.138
  11. Aspirin therapy in diabetes mellitus. Diabetologia. 1997 Jul; 40(7):867.
    View in: PubMed
    Score: 0.136
  12. Should we use intensive insulin therapy after oral agent failure in type II diabetes? Diabetes Care. 1996 Aug; 19(8):896-8.
    View in: PubMed
    Score: 0.128
  13. Vascular thrombosis in type II diabetes mellitus. Diabetes. 1993 Jan; 42(1):8-11.
    View in: PubMed
    Score: 0.100
  14. Clinical trials of antiplatelet agents in diabetes mellitus: rationale and results. Semin Thromb Hemost. 1991 Oct; 17(4):439-44.
    View in: PubMed
    Score: 0.091
  15. Pathophysiology of vascular disease in diabetes: effects of gliclazide. Am J Med. 1991 Jun 24; 90(6A):50S-54S.
    View in: PubMed
    Score: 0.090
  16. Aspirin for primary prevention of cardiovascular events in people with diabetes. J Am Coll Cardiol. 2010 Jun 22; 55(25):2878-86.
    View in: PubMed
    Score: 0.084
  17. A review of the development of large-vessel disease in diabetes mellitus. Am J Med. 1988 Nov 28; 85(5A):113-8.
    View in: PubMed
    Score: 0.075
  18. Antiplatelet agents and diabetic vascular disease. Trans Am Clin Climatol Assoc. 1987; 98:119-27.
    View in: PubMed
    Score: 0.066
  19. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Diabetes Care. 1986 Mar-Apr; 9(2):140-8.
    View in: PubMed
    Score: 0.062
  20. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics. Horm Metab Res Suppl. 1985; 15:69-73.
    View in: PubMed
    Score: 0.057
  21. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics. Control Clin Trials. 1984 Jun; 5(2):165-83.
    View in: PubMed
    Score: 0.055
  22. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med. 1983 Nov 30; 75(5B):67-80.
    View in: PubMed
    Score: 0.053
  23. Do platelets have anything to do with diabetic microvascular disease? Diabetes. 1983 May; 32 Suppl 2:14-9.
    View in: PubMed
    Score: 0.051
  24. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care. 1981 Jan-Feb; 4(1):121-33.
    View in: PubMed
    Score: 0.043
  25. Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results. Diabetes. 1996 Jul; 45 Suppl 3:S87-90.
    View in: PubMed
    Score: 0.032
  26. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995 Aug; 18(8):1113-23.
    View in: PubMed
    Score: 0.030
  27. Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes. Diabetes Care. 1995 Aug; 18(8):1150-5.
    View in: PubMed
    Score: 0.030
  28. Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM) Diabetes Care. 1992 Nov; 15(11):1560-71.
    View in: PubMed
    Score: 0.025
  29. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes. 1985 Nov; 34(11):1127-33.
    View in: PubMed
    Score: 0.015
  30. Platelet function in diabetes mellitus. Br J Haematol. 1980 Apr; 44(4):521-6.
    View in: PubMed
    Score: 0.010
  31. A critical issue. Intensive insulin treatment and macrovascular disease. Diabetes Care. 1998 Apr; 21(4):669-71.
    View in: PubMed
    Score: 0.009
  32. Altered platelet function in diabetes mellitus. Diabetes. 1976; 25(2 SUPPL):826-31.
    View in: PubMed
    Score: 0.008
  33. Increased platelet aggregation in early diabetus mellitus. Ann Intern Med. 1975 Jun; 82(6):733-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.